Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Avelumab may benefit some patients with advanced unresectable mesothelioma

February 20, 2019 By Law Offices of Thomas J. Lamb, P.A.

The anti-programmed cell death ligand 1 (PD-L1) monoclonal antibody avelumab is well tolerated and shows antitumor activity in some patients with previously treated unresectable mesothelioma, according to results from a single-arm trial.

“Immune-checkpoint inhibitors result in clinical benefit in a small subset of patients with mesothelioma, but the benefits can be durable in these patients,” Dr. Raffit Hassan from the National Cancer Institute, in Bethesda, MD, told Reuters Health by email.

Dr. Hassan and colleagues from the JAVELIN Solid Tumor trial assessed the efficacy and safety of avelumab (10 mg/kg every 2 weeks) in a phase 1b single-arm study of 53 patients with unresectable mesothelioma that progressed after platinum and pemetrexed treatment.

Of these 53 patients, one (2%) had a confirmed complete response, four (8%) had a confirmed partial response, and 26 patients (49%) had a best response of stable disease, which translates into an overall response rate of 9% and a disease-control rate of 58%, the researchers report JAMA Oncology, online January 3, 2019.

[Article continues at original source]

 Mesothelioma, Asbestos, and Legal Compensation: Basic Facts

Asbestos-Mesothelioma Case Evaluation Form
Free.  Confidential.  No Obligation.

Filed Under: Mesothelioma Tagged With: asbestos cancer, mesothelioma, mesothelioma treatments

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.